Manhattan Research Survey Finds That Physicians Overwhelmingly Support Commercially-Funded Continuing Medical Education
Posted on: Tuesday, 27 January 2009, 07:00 CST
In an effort to better understand the positions of those who actually use continuing medical education, Manhattan Research surveyed physicians on their opinions with regard to their use and the potential bias of industry-funded programs. The Manhattan Research study reports that only 8% of physicians who participated in CME believe that it is biased. In fact, if commercial support is halted, nearly half of the physicians surveyed would decrease their use of CME.
According to the study, almost all physicians utilize CME programs to maintain and grow their medical knowledge and to keep up-to-date on the latest advances in their specialty with the ultimate goal of improving patient care. Pharmaceutical companies are a funding source for CME programs, which has prompted some critics to question their influence over CME course content. In response, the Accreditation Council for Continuing Medical Education (ACCME), the organization that accredits CME Providers, has augmented its standards and guidelines to ensure the independence of commercially supported CME activities. The American Medical Association's Council on Ethical and Judicial Affairs (CEJA) is also expected to issue a new report on commercially-supported CME later this year.
"While there's been debate around the value of industry-supported CME, as our study reveals, it's important to listen to the voice of the majority of physicians," said
About the Study
Healthcare market research firm Manhattan Research conducted a survey to gauge physician opinion on commercially-funded CME and the proposed ban. The online study was fielded in the third quarter of 2008 among a nationally representative sample of U.S. physicians, including primary care and specialist audiences.
Manhattan Research, a Decision Resources, Inc. company, is a leading market research and advisory firm for pharmaceutical and healthcare companies. For more information, visit http://www.manhattanresearch.com, email sales@manhattanresearch.com or call 1.888.680.0800.
About Decision Resources, Inc.
Decision Resources, Inc. is a cohesive portfolio of companies that offers best-in-class, high-value information and insights on important sectors of the healthcare industry. Clients rely on this analysis and data to make informed decisions. Please visit Decision Resources, Inc. at http://www.DecisionResourcesInc.com.
All company, brand, or product names contained in this document may be trademarks or registered trademarks of their respective holders.
For more information, contact: Manhattan Research Maureen Malloy 212-255-7799 mmalloy@manhattanresearch.com Decision Resources, Inc. Elizabeth Marshall 781-296-2563 emarshall@dresources.comSOURCE Manhattan Research
Source: PR Newswire
Related Articles
- Hill Physicians Medical Group Joins the Alliance CompleteCare Physician Network
- Southeast Texas Biomedical Research Institute Announces Ambitious Plan: Build Biomedical Research Center and Medical School Northeast of Houston
- Howlett Research Corp. Publishes New Research Report on Coral Gold Resources Ltd.
- 2007 Analysis and Research Report on China Solar Grade Multicrystal Silicon Industry
- Hill Physicians Medical Group Named Among Top Medical Groups By Integrated Healthcare Association for Fourth Consecutive Year
- AFO Research's Next Generation Specialty Optical Glasses Provide Market Changing Opportunities for Medical, Commercial Laser, and Communications Industries
- Howlett Research Corp. Publishes Research Report on Coral Gold Resources Ltd.
- Peter B. Berger, M.D., Named Associate Chief Research Officer for Clinical Studies at Geisinger Health System
- SIDMAP Provides Metabolic Phenotyping Services to Researchers at Harvard Medical School's Joslin Diabetes Center and the University of Utah
- Renowned Researchers, Doctors Challenge Recent Study and Say 'Keep Taking Vitamin E'
 |
 |
User Comments (0)
RSS Feeds